Granite Point Capital Management, L.P. Applied Therapeutics Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$29.41 - $51.23 $1.12 Million - $1.96 Million	-38,240 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$19.54 - $55.47 $514,664 - $1.46 Million	26,339 Added 221.32%	38,240 $1.25 Million
Q4 2019 Feb 10, 2020	BUY	$10.16 - $28.14 $120,914 - $334,894	11,901 New	11,901 $325,000

141

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $27.4M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.